Regenerative Medical Technology Group Inc. Balance Sheet
RMTG|9 years of annual SEC 10-K data (FY2017-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 9 fiscal years. All figures from audited SEC 10-K filings.
Regenerative Medical Technology Group Inc. had $4M in total assets with negative shareholders' equity of $35M as of FY2025. Total debt was $4 against $956,718 in cash, resulting in a $956,714 net cash position.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $956.7K | - | $530.5K | $1.6M | $3.0M | $42.5K | $23.4K | $30.8K | $7.8K |
| Accounts Receivable | $43.8K | - | - | - | - | - | - | - | - |
| Inventory | $159.3K | $10.1K | - | - | - | - | - | - | - |
| Current Assets | $1.2M | $1.2M | $575.0K | $1.7M | $3.0M | $42.5K | $23.4K | $30.8K | - |
| PP&E (Net) | $870.8K | $451.7K | $359.3K | $186.3K | $22.9K | $2.2K | $3.0K | $3.8K | - |
| Goodwill | $1.7M | $1.7M | $1.7M | $5.8M | $5.8M | - | - | - | - |
| Total Assets | $4.5M | $3.8M | $2.9M | $8.1M | $9.3M | $219.7K | $26.4K | $34.6K | - |
| Current Liabilities | $36.8M | $29.0M | $22.2M | $12.0M | $4.2M | $914.5K | $7.0M | $4.6M | - |
| Total Debt | $4 | - | - | - | - | - | - | - | - |
| Shareholders' Equity | -$34.7M | -$27.4M | -$21.8M | -$12.0M | -$6.8M | -$6.4M | -$7.4M | -$4.5M | -$2.6M |